Ventripoint Diagnostics Ltd. announces that the Board of Directors of the Company had deemed the Company was no longer a going concern and elected to put the Company into receivership. Subsequently, Dr. Don Segal, David Willis, Dr. Alan Rabinowitz have resigned as Directors of the Company. Justin Leuschner has resigned as a Director and CEO of the Company.

Ellen Briant has resigned as CFO. Desmond Hirson has resigned as the CTO and will be available to the Company as a consultant. The Company has given notice to its employees and has stopped operations until new funds are secured.

A restructuring plan has been put together by Dr. George Adams, who will become the Executive-Chairman of the Company and will run the Company in the interim. Peter Weichler and Robert Hodgkinson have joined the Board of Directors as independent directors. The Company has initiated a search for a new CEO and CFO.

Robert Hodgkinson has over 40 years of experience in public and venture capital markets. He has raised $150 + of capital for numerous companies and is an experienced corporate director, senior executive and adviser. He has been instrumental in successful merger and acquisitions in oil and gas transactions totaling $500 mm+ and has acted as a principal and agent in corporate structuring/r estructuring.

Peter Weichler is presently a partner in the firm Candela Capital based in Calgary. His background in finance includes commercial banking, stock brokerage, investor relations and investment banking with national Canadian firms. He is well versed in capital raising for emerging and entrepreneurial public companies.